Dr. Vasu Tumati, MD

Dr. Tumati practices at Ascension St. Vincent Hospital - Indianapolis in Indianapolis, Indiana, part of Ascension Health Alliance.

Dr. Tumati's NPI, 1205272333, was assigned on May 15, 2013. Dr. Tumati holds Indiana license 01080386A.

Dr. Tumati's primary practice is Ascension St. Vincent Hospital - Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-7000.

Dr. Tumati's primary practice is Ascension St. Vincent Hospital - Indianapolis in Indianapolis, Indiana, part of Ascension Health Alliance. Dr. Tumati is also affiliated with HCA Houston Healthcare West. The medical group on file is Cancer Care Group. Dmand AI also links Dr. Tumati to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tumati practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tumati's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tumati is licensed in Indiana.

CMS data shows 946 Medicare services from Dr. Tumati across 17 procedure codes in 2024, for 289 Medicare patients. Medicare paid $56,879 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 289 Medicare patients who saw Dr. Tumati in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tumati's median patient age at 73, with 50% women.

In 2024, Dr. Tumati wrote 283 Medicare Part D claims for 111 patients. 97% of them were for generic drugs. CMS names the drug for 183 of them, across 6 drugs with 11 or more claims each, at $1,632 in total drug cost. In 2023, CMS named 149 claims across 5 drugs.

Dr. Tumati accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Tumati, published from 2012 to 2019. 2012 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Neoplasm Grading. Dr. Tumati has published most often in Int J Radiat Oncol Biol Phys. Dr. Tumati's most frequent co-authors are Michael Ryan Folkert, MD, PhD, Raquibul Hannan, MD, PhD and Brent Keith Hollenbeck, MD.

CMS Open Payments shows 6 general payments to Dr. Tumati from 6 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $22.